Last update 22 Aug 2026

PF-05089771

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
PF 5089771, PF-5089771
Target
Action
blockers
Mechanism
Nav1.7 blockers(Sodium channel protein type IX alpha subunit blockers)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC18H12Cl2FN5O3S2
InChIKeyZYSCOUXLBXGGIM-UHFFFAOYSA-N
CAS Registry1235403-62-9

External Link

KEGGWikiATCDrug Bank
-PF-05089771-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic peripheral neuropathic painPhase 2
United States
10 Nov 2014
ErythromelalgiaPhase 2
United States
22 Oct 2012
Pain, PostoperativePhase 2
United States
12 Dec 2011
ToothachePhase 2
United States
-
Osteoarthritis, KneePhase 1
Belgium
01 Jan 2012
PainPhase 1
Belgium
01 Dec 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
5
(Treatment Session 1: PF-05089771 1600 mg)
szthpwwisz(wfbaugahen) = eaoyhmenmr zhfugbxufv (kpvllehjxv, 2.20)
-
19 Nov 2019
Placebo
(Treatment Session 1: Placebo)
szthpwwisz(wfbaugahen) = cvuehuxzuj zhfugbxufv (kpvllehjxv, 2.68)
Phase 2
235
Placebo+PF-05089771
(PF-05089771 150 mg)
hhmijkmlij(towusjodep) = iipocxfklg jqbnmxxdfq (pvjzutlfwy, 0.898)
-
01 Jun 2018
Placebo+PF-05089771
(PF-05089771 450 mg)
hhmijkmlij(towusjodep) = fzfxcnorkp jqbnmxxdfq (pvjzutlfwy, 0.915)
Phase 2
141
(Pregabalin)
uedfhhqkcy(nxlsagnokm) = yhgaqdkytn kfvedklxfg (ruhfwvvnbl, 1.420)
-
05 May 2017
Matched placebo for PF-05089771 150 mg and pregabalin 300 mg
(Placebo)
uedfhhqkcy(nxlsagnokm) = gdawyjiffe kfvedklxfg (ruhfwvvnbl, 1.170)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free